Últimas noticias sobre Arthur J. Gallagher (NYSE:AJG) Bolsa

ARTHUR J GALLAGHER & CO

Arthur J. Gallagher

Founded in 1927 as a one-person agency, Gallagher's primary business is insurance brokerage, with a focus on serving middle-market companies. The company's risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 56,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.

Arthur J. Gallagher & Co

ATLANTIS JPN GRWTH FD ORD by Atlantis Japan Growth Fund

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>)</h3>
<ul class="wp-block-list">
<li>On June 9, Wells Fargo analyst Elyse Greenspan maintained Arthur J. Gallagher with an Overweight rating and lowered the price target from $372 to $371. The company's stock fell around 9% over the past five days and has a 52-week low of $251.42.</li>
<li>RSI Value: 29.9</li>
<li>AJG Price Action: Shares of Arthur J. Gallagher fell 3.3% to close at $317.83 on Monday.</li>
<li>Edge Stock Ratings: 83.63 Momentum score with Value at 19.39. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/AJG"><img loading="lazy" decoding="async" width="402" height="185" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065801/image-135.png" alt="" class="wp-image-944508" style="width:272px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065801/image-135.png 402w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065801/image-135-300x138.png 300w" sizes="(max-width: 402px) 100vw, 402px" /></a></figure>
<h3 class="wp-block-heading">Compass Diversified Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CODI#NYSE">CODI</a>)&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On May 27, Compass Diversified Holdings announced it entered into a diversified forbearance agreement and cut its management fees and quarterly dividend. Additionally, the company received a NYSE late filing notice amid an investigation into financial irregularities for its subsidiary. The company's stock fell around 7% over the past month and <a href="https://www.benzinga.com/quote/CODI">has a 52-week low</a> of $6.05.</li>
<li>RSI Value: 24</li>
<li>CODI Price Action: Shares of Compass Diversified fell 8.6% to close at $6.56 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0610">CODI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0610"><img loading="lazy" decoding="async" width="923" height="846" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065901/image-136.png" alt="" class="wp-image-944510" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065901/image-136.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065901/image-136-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10065901/image-136-768x704.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<h3 class="wp-block-heading">CURRENC Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>)</h3>
<ul class="wp-block-list">
<li>On May 20, Currenc Group posted downbeat quarterly results. &#8220;As demand for digital remittance continues to grow steadily, intensified market competition is compressing pricing,&#8221; said Alex Kong, Founder and Executive Chairman of Currenc. &#8220;Against this backdrop, we strove to maintain Tranglo&#8217;s healthy take rate while delivering TPV of US $1.30 billion in the first quarter of 2025, underscoring the strength of our core remittance platform and our disciplined strategic execution.&#8221; The company's stock fell around 51% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/CURR">low of $0.44</a>.</li>
<li>RSI Value: 26.2</li>
<li>CURR Ltd Price Action: Shares of CURRENC Group gained 1.6% to close at $0.51 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0610">CURR shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0610"><img loading="lazy" decoding="async" width="887" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10070002/image-137.png" alt="" class="wp-image-944511" style="width:583px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10070002/image-137.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10070002/image-137-300x284.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10070002/image-137-768x727.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45836136/5-stocks-in-the-spotlight-from-wall-streets-most-accurate-analysts-last-week-4">5 Stocks In The Spotlight From Wall Street&#8217;s Most Accurate Analysts Last Week</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

CODI

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

Top 3 Financial Stocks That Could Lead To Your Biggest Gains This Month

Wells Fargo analyst Elyse Greenspan maintains Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) with a Overweight and lowers the price target from $372 to $371.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Arthur J. Gallagher, Lowers Price Target to $371

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol class="wp-block-list">
<li>Lululemon Athletica Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock dipped 16.23% after the company reported first-quarter results and<a href="https://www.benzinga.com//node/45819605" target="_blank" rel="noreferrer noopener"> analysts revised the price forecast</a>.</li>
<li>Brown Forman Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) shares tumbled 15.69% after the company reported <a href="https://www.benzinga.com//node/45793814" target="_blank" rel="noreferrer noopener">worse-than-expected financial results</a> due to the trade war and tariffs. Analysts lowered the price <a href="https://www.benzinga.com/quote/bf-b/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast on the stock</a>.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) shares declined 15.04% after the company reported first-quarter results and analysts <a href="https://www.benzinga.com//node/45818750" target="_blank" rel="noreferrer noopener">revised the price forecast</a>.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock decreased 14.81%, possibly due to Elon Musk&#8217;s departure from the White House and his ongoing <a href="https://www.benzinga.com//node/45805173" target="_blank" rel="noreferrer noopener">feud with President Trump</a>.</li>
<li>Ciena Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) shares fell 9.17% after reporting worse-than-expected <a href="https://www.benzinga.com//node/45788812" target="_blank" rel="noreferrer noopener">second-quarter results</a>. Several analysts revised <a href="https://www.benzinga.com//node/45822276" target="_blank" rel="noreferrer noopener">the price forecast</a> for Ciena stock.</li>
<li>Kenvue Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) stock dived 8.97%.</li>
<li>Kimberly-Clark Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NASDAQ">KMB</a>) shares were down 7.10%. Last week, Suzano S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUZ#NYSE">SUZ</a>) rolled up $3.4 billion in <a href="https://www.benzinga.com//node/45797473" target="_blank" rel="noreferrer noopener">a tissue deal with Kimberly-Clark</a>.</li>
<li>Pearson, Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSO#NYSE">PSO</a>) shares decreased 6.08% last week.</li>
<li>FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) stock declined 5.65%. The Board of Directors has appointed Sanoke Viswanathan as Chief Executive Officer, <a href="https://www.benzinga.com//node/45742153" target="_blank" rel="noreferrer noopener">effective early September 2025</a>.</li>
<li>Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) shares were down 5.38% last week.</li>
</ol>
Image Via Shutterstock

Equities

Large Cap

Movers

CIEN

DOCU

KVUE

LULU

TSLA

Tesla And Lululemon Are Among Top 10 Large-Cap Losers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) with a Market Perform and raises the price target from $315 to $326.

Keefe, Bruyette & Woods Maintains Market Perform on Arthur J. Gallagher, Raises Price Target to $326

Arthur J. Gallagher & Co. Acquires Wilkins & Associates Insurance Services; Terms Not Disclosed

Reported Earlier, Gallagher Named Official Insurance Broker For The All Blacks, Black Ferns, Māori All Blacks, And Sevens Teams

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) has outperformed the market over the past 15 years by 7.09% on an annualized basis producing an average annual return of 18.88%. Currently, Arthur J. Gallagher has a market capitalization of $87.65 billion. 
Buying $1000 In AJG: If an investor had bought $1000 of AJG stock 15 years ago, it would be worth $13,842.11 today based on a price of $342.75 for AJG at the time of writing.
<h3>Arthur J. Gallagher's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748445311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Arthur J. Gallagher Stock In The Last 15 Years

UnitedHealth Group Inc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) <a href="https://www.benzinga.com/quote/UNH/news">recent nosedive wasn't just a chart pattern</a> — it was a conviction breaker. 
Tom Hulick, CEO of Strategy Asset Managers, didn't wait for a rebound. He dumped the stock, citing "a deterioration in fundamentals" in exclusive insights shared with Benizinga over email.
UnitedHealth&#8217;s stock is down over 42% year-to-date, over 31% down in the past month alone.
<h2 class="wp-block-heading">Asset Manager Walks Away From UNH Stock</h2>
The asset manager's exit from UnitedHealth stock followed a string of gut punches for UnitedHealth: an unexpected CEO resignation, fiscal 2025 guidance withdrawal, and what Hulick called "a rare earnings miss and downward revisions to EPS." But the real red flag?
A company that always looked forward suddenly stopped doing so. "When a perennial compounder stops providing forward guidance and leadership turnover coincides with performance slippage, it's a signal to pay attention."
Read Also: <a href="https://www.benzinga.com/general/health-care/25/05/45486314/unitedhealth-ceo-other-insiders-buy-millions-in-stock-as-it-sinks-over-23-in-a-week-move-gets-mixed-reaction">UnitedHealth CEO, Other Insiders Buy Millions In Stock As It Sinks Over 23% In A Week</a>
<h2 class="wp-block-heading">The Storm Brewing In Medicare Advantage</h2>
And Hulick's attention is now on a storm brewing in Medicare Advantage. Once UnitedHealth's profit engine, it's now showing signs of burnout. "Rising utilization, tighter reimbursement, and structural adjustments tied to the CMS risk model transition" have created a perfect storm, Hulick said, adding that "margin compression at a scale that can't be resolved with typical cost controls" could lead to slower growth or even retrenchment.
The broader picture isn't much rosier for the managed care sector. With regulators circling and medical loss ratios climbing, Hulick says the core business model is losing its shine. "The upside appears capped relative to prior cycles," he said, noting a shift in the defensive-growth balance that "is not necessarily in favor of the incumbents."
<h2 class="wp-block-heading">Going Long On Science, Instead</h2>
So where is the $700 million manager putting its chips? Hulick is going long on science. "We're investing in innovation-driven segments that offer idiosyncratic upside and aren't tethered to reimbursement dynamics."
That includes early-stage biotech, gene editing, and longevity plays &#8211; plus global insurance firms like Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>), which Hulick says have "demonstrated durable growth, pricing power, and operate in areas less exposed to the volatility we're seeing in U.S. health insurance."
UNH may be the canary in the managed care coal mine. While Hulick sees "rising costs, regulatory friction, and deteriorating visibility" across the sector, he singles out UnitedHealth as "uniquely exposed" given its size, complexity, and "integration challenges-especially with Optum."
The firm has exited UnitedHealth across three equity strategies but is holding onto bonds maturing in 2026 &#8211; one place where Hulick still sees strength. "The A+ rating and balance sheet strength remain intact."
But in equities, the message is clear: "The focus now is on innovation, not incumbency."
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45487788/trumps-drug-price-order-hits-pbms-hardest-cvs-cigna-unh-in-focus-as-experts-highlight-racket-and-pricing-distortion">Trump&#8217;s Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight &#8216;Racket,&#8217; Pricing Distortion</a></li>
</ul>
Image: Shutterstock

Analyst Color

Health Care

Exclusives

Interview

General

EXCLUSIVE: UnitedHealth Gets Dumped, Why This Asset Manager Says Insurer Is No Longer A Safe Bet

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) has outperformed the market over the past 20 years by 4.89% on an annualized basis producing an average annual return of 13.11%. Currently, Arthur J. Gallagher has a market capitalization of $87.17 billion. 
Buying $100 In AJG: If an investor had bought $100 of AJG stock 20 years ago, it would be worth $1,184.20 today based on a price of $340.85 for AJG at the time of writing.
<h3>Arthur J. Gallagher's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747062088_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Arthur J. Gallagher's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) short percent of float has fallen 6.67% since its last report. The company recently reported that it has 3.49 million shares sold short, which is 1.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Arthur J. Gallagher Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746810026_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Arthur J. Gallagher has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Arthur J. Gallagher's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Arthur J. Gallagher's peer group average for short interest as a percentage of float is 2.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is the Market Bullish or Bearish on Arthur J. Gallagher?

Arthur J. Gallagher & Co. Acquires Dean R. Casey & Associates; Terms Not Disclosed

Arthur J. Gallagher Acquires Türkiye's Aspera To Strengthen Insurance And Reinsurance Brokerage Footprint

U.S. stocks advanced across the board by midday Friday, with the S&amp;P 500 eyeing its ninth consecutive day of gains—poised for the longest winning <a href="https://www.benzinga.com/markets">streak since May 2024.</a>
Risk appetite remained firm, underpinned by solid corporate earnings and a stronger-than-expected April jobs report. Nonfarm payrolls rose by 177,000, beating expectations of 130,000 and easing concerns over tariff-related hiring slowdowns.
All eleven S&amp;P 500 sectors traded in positive territory, led slightly by financials over technology. Major indexes have now fully recovered from the declines sparked on April 2, when President Donald Trump announced sweeping tariffs across trading partners.
The Nasdaq 100 climbed to levels last seen in late March, capping a strong week for tech stocks. Among the Magnificent Seven, all were on pace to close the week higher except Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), which slipped 4% as strong earnings were overshadowed by weaker sales in China.
The U.S. dollar index resumed its decline, pressured by renewed calls from President Trump for the Federal Reserve to lower interest rates ahead of next week's policy meeting.
Treasury yields surged following the upbeat jobs data, with the 10-year note jumping 10 basis points to 4.31%, easing recession concerns entering the second quarter.
In commodities, oil prices fell back to $58 per barrel despite Thursday's rally on heightened geopolitical tensions in the Middle East. Gold rebounded 0.5%, set to snap a three-day losing streak, while natural gas prices jumped 4.4% to a two-week high.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged up 1% to $97,500, marking its fourth straight week of gains.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,009.90</td>
<td>+1.7%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,052.42</td>
<td>+1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,671.17</td>
<td>+1.2%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,130.34</td>
<td>+0.9%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 11:30 a.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 1.2% to $565.03.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.9% to $411.29.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rallied 1.4% to $488.26.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) soared 1.8% to $199.58.</li>
<li>The&nbsp;Financials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) outperformed, up 1.7%; the&nbsp;Consumer Staples&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) lagged, up 0.3%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
Stocks reacting to earnings reports included: 
<ul>
<li>Apple Inc.: down 4.0%</li>
<li>Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): up 0.2%</li>
<li>Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>): up 0.0%</li>
<li>Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>): up 0.7%</li>
<li>Eaton Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>): down 2.1%</li>
<li>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>): down 1.8%</li>
<li>Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>): down 0.5%</li>
<li>Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>): up 3.5%</li>
<li>Monolithic Power Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>): up 4.0%</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>): up 14.2%</li>
<li>Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>): down 1.7%</li>
<li>T. Rowe Price Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>): up 3.5%</li>
<li>Cboe Global Markets, Inc. (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>): up 1.2%</li>
<li>Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>): up 1.4%</li>
<li>Live Nation Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>): up 0.1%</li>
<li>Motorola Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>): down 6.2%</li>
<li>Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>): down 0.2%</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45166673/trump-pressures-fed-after-solid-jobs-cooling-inflation-lower-rates-now">Trump Pressures Fed After Solid Jobs, Cooling Inflation: &#8216;Lower Its Rate!&#8217; (CORRECTED)</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Broad U.S. Equity ETFs

Commodities

Econ #s

Economics

Tech

ETFs

$BTC

AAPL

ABNB

AMGN

AMZN

CBOE

SPDR Dow Jones Industrial Average ETF Trust

DXCM

MPWR

TROW

Select Sector SPDR-Consumer Discretionary

Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday?

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) with a Market Perform and raises the price target from $307 to $315.

Keefe, Bruyette & Woods Maintains Market Perform on Arthur J. Gallagher, Raises Price Target to $315

WIIM

Arthur J. Gallagher shares are trading higher after the company reported better-than-expected Q1 financial results.

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) reported quarterly earnings of $3.67 per share which beat the analyst consensus estimate of $3.58 by 2.51 percent. This is a 5.16 percent increase over earnings of $3.49 per share from the same period last year. The company reported quarterly sales of $3.73 billion which beat the analyst consensus estimate of $3.68 billion by 1.34 percent. This is a 14.44 percent increase over sales of $3.26 billion the same period last year.

Earnings

Earnings Beats

Arthur J. Gallagher Q1 Adj. EPS $3.67 Beats $3.58 Estimate, Sales $3.73B Beat $3.68B Estimate

Editor&#8217;s Note: The article has been udpated to correct the Stock Movers list.
Wall Street pushed higher in midday trading, with the S&amp;P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully recovering the losses sustained after former President Donald Trump announced <a href="https://www.benzinga.com/topic/tariffs">trade tariffs on April 2.</a>
Technology stocks led the rally, with the Nasdaq 100 climbing 1.5%. Strong and resilient corporate earnings continue to fuel investor appetite for risk, helping markets shrug off recent tariff concerns.
President Trump reassured investors, stating that progress on trade negotiations is going "very well" and that the timeline for the tax bill remains on schedule.
On the economic front, data continued to paint a weaker picture. After Wednesday's disappointing first-quarter GDP report, the ISM manufacturing PMI showed factory activity contracted for the second straight month in April. Meanwhile, price pressures surged at the fastest pace since June 2022, reflecting <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45139383/us-manufacturing-activity-contracts-in-april-as-tariffs-push-input-prices-toward-3-year-highs">inflationary effects from tariffs.</a>
Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>) was a standout gainer, soaring 8.60% after delivering a blowout quarter that beat expectations across the board, reinforcing its leadership in cloud and AI. The stock reached its highest level since late January.
Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) also topped estimates, with shares climbing more than 4%.
Sector-wise, technology outperformed, while health care lagged. Eli Lilly And Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) plunged over 9% after the pharmaceutical giant cut its 2025 guidance.
Crude oil erased early losses, rebounding to $58 per barrel after briefly dipping below $57. Gold slipped 2.2% to a two-week low.
The U.S. dollar strengthened to its highest level in over two weeks, bolstered by manufacturing surveys showing rising input costs tied to tariffs.
Treasury yields climbed for a second straight session, with the 10-year yield rising to 4.21%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) surged past the $97,000 mark, hitting its highest level in over two months.
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>% chg.</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,853.70</td>
<td>+ 1.5%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,614.89</td>
<td>+ 0.9%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,971.76</td>
<td>+ 0.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,802.25</td>
<td>+ 0.3%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:55 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 1% to $560.02.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.5% to $408.25.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 1.6% to $483.23.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.5% higher to $195.71.</li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 2.6%; the&nbsp;Health Care&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 2.3%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
Stocks reacting to earnings reports included: Microsoft Corporation: up 8.30% Meta Platforms, Inc.: up 4.29% Eli Lilly And Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>): &#8211; 9.88% Mastercard Incorporated&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>): -0.20% McDonald's Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>): -1.24% Linde plc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>): -1.14% Qualcomm Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>): -8.28% KKR &amp; Co. Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>): up 1.19% The Southern Company&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>): up 0.22% Intercontinental Exchange, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>): up 1.83% KLA Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>): -2.43% CVS Health Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>): up 6.23% Equinix, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>): -0.16% Parker-Hannifin Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>): up 0.70% Air Products and Chemicals, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>): -0.09% Howmet Aerospace Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>): up 7.44% Carrier Global Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>): up 11% Aflac Incorporated&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>): -4% Public Storage&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>): -0.18% The Allstate Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>): -1.27% MetLife, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>): up 0.47% W.W. Grainger, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>): Up 2.14% Becton, Dickinson and Company&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>): -15.73% Quanta Services, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>): up 10.10% Exelon Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>): -0.33% Dominion Energy, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>): up 0.91%
Stocks slated to report earnings after the bell include Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>), Airbnb Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), Atlassian Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>), Motorola Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>), EOG Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>), American International Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>), Consolidated Edison Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>), Ingersoll Rand Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IR#NYSE">IR</a>), DexCom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>), Monolithic Power Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>), Ameren Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEE#NYSE">AEE</a>), GoDaddy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>), Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>), MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>), Hologic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>), Mohawk Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>), Camden Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) and Live Nation Entertainment Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>).
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45117801/apple-q2-earnings-preview-analysts-remain-bullish-with-caution-of-tariff-tornado-hitting-iphone">Apple Q2 Earnings Preview: Analysts Remain Bullish But Warn Of &#8216;Tariff Tornado&#8217; Hitting iPhone</a></li>
</ul>
Photo: Shutterstock

Government

Regulations

Sector ETFs

CARR

EQIX

GDDY

HOLX

KLAC

MSFT

MSTR

QCOM

TEAM

Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday? (CORRECTED)

AAMI

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMWL

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

ECVT

ELME

Earnings Scheduled For May 1, 2025

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement.
Analysts estimate that Arthur J. Gallagher will report an earnings per share (EPS) of $3.85. 
Anticipation surrounds Arthur J. Gallagher's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.10, leading to a 0.93% increase in the share price on the subsequent day.
Here's a look at Arthur J. Gallagher's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.03</td>
<td>2.27</td>
<td>2.24</td>
<td>3.41</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.13</td>
<td>2.26</td>
<td>2.26</td>
<td>3.49</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>4.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746021680_0.png" alt="eps graph" />
<h3>Tracking Arthur J. Gallagher's Stock Performance</h3>
Shares of Arthur J. Gallagher were trading at $317.14 as of April 29. Over the last 52-week period, shares are up 31.5%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Insights Shared by Analysts on Arthur J. Gallagher</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Arthur J. Gallagher.
With 10 analyst ratings, Arthur J. Gallagher has a consensus rating of Neutral. The average one-year price target is $324.1, indicating a potential 2.19% upside.
<h3>Peer Ratings Comparison</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Aon, Marsh &amp; McLennan Cos and Brown &amp; Brown, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Aon, with an average 1-year price target of $408.22, suggesting a potential 28.72% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Marsh &amp; McLennan Cos, with an average 1-year price target of $233.78, suggesting a potential 26.28% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Brown &amp; Brown, with an average 1-year price target of $119.67, suggesting a potential 62.27% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary outlines pivotal metrics for Aon, Marsh &amp; McLennan Cos and Brown &amp; Brown, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arthur J. Gallagher</td>
<td>Neutral</td>
<td>11.68%</td>
<td>$1.13B</td>
<td>1.60%</td>
</tr>
<tr>
<td>Aon</td>
<td>Outperform</td>
<td>16.19%</td>
<td>$2.48B</td>
<td>14.70%</td>
</tr>
<tr>
<td>Marsh &amp; McLennan Cos</td>
<td>Neutral</td>
<td>9.08%</td>
<td>$3.21B</td>
<td>10.08%</td>
</tr>
<tr>
<td>Brown &amp; Brown</td>
<td>Neutral</td>
<td>11.96%</td>
<td>$702M</td>
<td>4.94%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Arthur J. Gallagher ranks in the middle among peers for revenue growth. It is at the bottom for gross profit and return on equity.
<h3>All You Need to Know About Arthur J. Gallagher</h3>
Founded in 1927 as a one-person agency, Gallagher's primary business is insurance brokerage, with a focus on serving middle-market companies. The company's risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 56,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.
<h3>Breaking Down Arthur J. Gallagher's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Arthur J. Gallagher's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 11.68%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Arthur J. Gallagher's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.51% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.6%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Arthur J. Gallagher's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.43%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.67.
<a href="https://www.benzinga.com/quote/AJG/earnings">To track all earnings releases for Arthur J. Gallagher visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Arthur J. Gallagher

Arthur J. Gallagher & Co. Acquires First Capital Financial Services; Terms Not Disclosed

Insurance

Press Releases

Arthur J. Gallagher & Co. Completes Acquisition of Woodruff Sawyer

Arthur J. Gallagher & Co. Acquires First Capital Financial Services

Dividends

Arthur J. Gallagher & Co. Announces Regular Second Quarter Dividend

Arthur J. Gallagher & Co. Announces First Quarter 2025 Financial Results

Arthur J. Gallagher & Co. Acquires Türkiye-based Aspera

Arthur J. Gallagher & Co. Acquires Dean R. Casey & Associates

Arthur J. Gallagher & Co. To Speak at S&P Global Ratings' 2025 Annual Insurance Conference and Host Regularly Scheduled Quarterly Investor Meeting

US Business Owners are Taking Extra Precautions to Safeguard Their Businesses, According to Gallagher Study

New Zealand Rugby and Gallagher Insurance announce multi-year global partnership

Arthur J. Gallagher & Co. Acquires Wilkins & Associates Insurance Services, Inc.

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

AIFU

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Cos

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Arthur J. Gallagher

Noticias

Últimas noticias sobre Arthur J. Gallagher (NYSE:AJG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL